ArticleTransplantation direct2025

Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney Transplantation.

Edmund Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.